Privacy & Cookies Policy
This website uses cookies to improve your experience. We'll assume
you're ok with this, but you can opt-out if you wish.Cookie settings
Analysis of a Switch From Enfuvirtide to Raltegravir in Patients with Undetectable Viral Load: Efficacy and Quality of Life at 24 Weeks. Journal of the International Association of Physicians in AIDS Care, 8(2): 85-86.
Author:
Chien C, Easley A, Hamwi G, Hershey-Weber J, Khanlou H, Nguyen T, Prosser P, Ricaurte JC, Sanchez S, Sayana S, Wilson L
Cookies Popup
This website uses cookies to improve your experience. We’ll assume you’re ok with this, but you can opt-out if you wish. [cookie_settings] [cookie_button]